权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

A Synthetic Approach to Calyxins and Epicalyxins I and J

萼蛋白和表萼蛋白 I 和 J 的合成方法

基本信息

批准号：
7126978
负责人：
KEITH Thomas MEAD
金额：
$ 20.93万
依托单位：
MISSISSIPPI STATE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2006
资助国家：
美国
起止时间：
2006-09-01 至 2009-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7126978
关键词：
Diels Alder reaction amides analog chemical addition human imines ions lead neoplasm /cancer sectioning

项目摘要

DESCRIPTION (provided by applicant): Three constituents of Alpinia blepharocalyx, namely calyxin I, calyxin J and epicalyxin J, are the subject of this proposal owing to their in vitro activity against human fibrosarcoma HT-1080 and murine colon 26-L5 carcinoma cells. The long-term objective of this research is to verify the absolute structures of these compounds by independent synthesis. Specifically this proposal will focus on one part of the puzzle, that being to develop a stereocontrolled approach to the fused ring system common to each compound. The research design is divided into three major sections. In section one, hetero Diels-Alder reactions between substituted dihydropyrans and N-acyl imines, leading to fused ring bicyclic acetals, will be studied. Section two focuses on Lewis acid ring cleavage reactions of these [4 + 2] cycloadducts with a variety of nucleophiles. The intended C-aryl pyranoside products will arise from nucleophilic addition of electron rich aromatic rings to oxocarbenium ions generated from these bicyclic acetals. The third section will concentrate on the application of this methodology to synthesis. Each product of ring cleavage should contain a side chain on C-2 of the tetrahydropyran ring which bears an amide moiety. A set of experiments will be designed to gradually increase the electron deficiency of this amide moiety by adding groups with increasing electron withdrawing capabilities. We hypothesize that in a Lewis acid environment, and with sufficient stabilization from neighboring groups, unimolecular dissociation of the amide functionality will lead to carbocation formation, allowing intramolecular substitution from a near-by nucleophilic center. This step is designed to provide the aforementioned three-membered fused ring system. The in vitro anti-cancer activity of these constituents makes them potential drug candidates for the treatment of human tumors. In collaboration with biologists on campus, their laboratory synthesis would eventually lead to the determination of how they kill cancer cells. Using this information, the design of analogues with superior and more selective cancer fighting properties should be possible.

描述（由申请人提供）：由于其对人纤维肉瘤HT-1080和鼠结肠26-L5癌细胞的体外活性，眼萼山姜的三种成分，即calyxin I、calyxin J和epicalyxin J是本发明的主题。本研究的长期目标是通过独立合成来验证这些化合物的绝对结构。具体来说，这项建议将集中在一个部分的难题，即开发一个立体控制的方法，以稠环系统共同的每一个化合物。研究设计分为三大部分。第一部分研究了取代二氢吡喃与N-酰基亚胺之间的杂Diels-Alder反应，得到稠环双环缩醛。第二部分主要研究了这些[4 + 2]环加合物与各种亲核试剂的刘易斯酸开环反应。预期的C-芳基吡喃糖苷产物将由富电子芳环与由这些双环缩醛产生的氧代碳正离子的亲核加成产生。第三部分将集中讨论这种方法在综合中的应用。每种环裂解产物应在四氢吡喃环的C-2上含有一个侧链，该侧链带有酰胺部分。将设计一组实验以通过添加具有增加的吸电子能力的基团来逐渐增加该酰胺部分的缺电子。我们假设，在刘易斯酸环境中，并与相邻基团的充分稳定，酰胺官能团的单分子解离将导致碳阳离子的形成，允许从附近的亲核中心的分子内取代。该步骤设计为提供上述三元稠环体系。这些成分的体外抗癌活性使它们成为治疗人类肿瘤的潜在候选药物。在与校园生物学家的合作中，他们的实验室合成最终将导致确定他们如何杀死癌细胞。利用这些信息，设计具有上级和更有选择性的抗癌特性的类似物应该是可能的。